Deal of The Day! Hurry Up, Grab the Special Discount - Save 25% - Ends In 00:00:00 Coupon code: SAVE25
Welcome to Pass4Success

- Free Preparation Discussions
Mail Us support@pass4success.com
Location US
Mob_nav_barsMENU

CIPS L4M6 Exam - Topic 3 Question 64 Discussion

Actual exam question for CIPS's L4M6 exam
Question #: 64
Topic #: 3
[All L4M6 Questions]

[Partnership and collaboration models]

Grey Stone Memorial Hospital is a private medical facility which has an idea for a vaccine to a deadly disease, but does not have the capacity to make the vaccine itself. It is considering partnering with a well-known pharmaceutical company in order to bring the vaccine to market. What is the biggest risk to Grey Stone?

Show Suggested Answer Hide Answer
Suggested Answer: A

by Lovetta at Jun 16, 2025, 05:07 PM

Limited Time Offer

25%

Off

Get Premium L4M6 Questions as Interactive Web-Based Practice Test or PDF

Contribute your Thoughts:

0/2000 characters
Submit Cancel
Trina
5 months ago
Wait, uninformed stakeholders could really derail this?
upvoted 0 times
...
Viola
5 months ago
I think increased costs are a bigger concern.
upvoted 0 times
...
Shelia
6 months ago
Totally agree with the IP rights risk!
upvoted 0 times
...
Lenita
6 months ago
Low quality product? That’s a real possibility!
upvoted 0 times
...
Nakisha
6 months ago
Intellectual property rights can be a huge risk in partnerships.
upvoted 0 times
...
Tonja
6 months ago
Uninformed stakeholders could definitely pose a problem, but I think the intellectual property rights issue might overshadow that in this scenario.
upvoted 0 times
...
Catarina
7 months ago
I feel like the quality of the product is crucial, but I don't know if that's the biggest risk. We talked about quality control in similar practice questions.
upvoted 0 times
...
Bulah
7 months ago
I'm not entirely sure, but I think increased costs could be a risk too. If the pharmaceutical company raises prices, it might affect Grey Stone's budget.
upvoted 0 times
...
Tegan
7 months ago
I remember discussing how intellectual property rights can be a major concern in partnerships, especially when sharing proprietary information.
upvoted 0 times
...
Anabel
7 months ago
Low quality product is an interesting option. If the hospital doesn't have full control over the manufacturing process, there's a risk the vaccine could end up being subpar. I'll have to weigh that against the other choices.
upvoted 0 times
...
Darci
7 months ago
Increased costs seems like the most likely answer here. Partnering with a big pharma company is going to come with a lot of overhead and fees that could really eat into the hospital's profits.
upvoted 0 times
...
Lashon
7 months ago
Hmm, I'm not sure about this one. There are a few potential risks to consider. I think I need to think through the different partnership models and how they could impact the hospital's position.
upvoted 0 times
...
Jolene
8 months ago
This seems like a pretty straightforward question. The biggest risk is probably intellectual property rights - the hospital might lose control of the vaccine formula if they partner with the pharmaceutical company.
upvoted 0 times
...
Cherelle
10 months ago
I agree, the IP rights are crucial. They better get a good lawyer to draw up that contract!
upvoted 0 times
Clarence
8 months ago
A) Intellectual Property Rights
upvoted 0 times
...
Lenny
8 months ago
D) Uninformed stakeholders
upvoted 0 times
...
Boris
8 months ago
C) Low quality product
upvoted 0 times
...
Maile
8 months ago
B) Increased Costs
upvoted 0 times
...
Sue
8 months ago
A) Intellectual Property Rights
upvoted 0 times
...
Merri
8 months ago
D) Uninformed stakeholders
upvoted 0 times
...
Bernardine
8 months ago
C) Low quality product
upvoted 0 times
...
Queenie
8 months ago
B) Increased Costs
upvoted 0 times
...
Lang
10 months ago
A) Intellectual Property Rights
upvoted 0 times
...
...
Isadora
10 months ago
Uninformed stakeholders? That's a good one. How about 'Disgruntled shareholders who can't get their hands on the vaccine first'?
upvoted 0 times
...
Gilberto
10 months ago
Low quality product is a risk too. They need to ensure the pharma company can manufacture the vaccine to their standards.
upvoted 0 times
Francene
9 months ago
B) Increased Costs
upvoted 0 times
...
Rebecka
9 months ago
A) Intellectual Property Rights
upvoted 0 times
...
...
Alverta
10 months ago
But what about B) Increased Costs? Partnering with a big company could lead to unexpected expenses for Grey Stone.
upvoted 0 times
...
Quiana
11 months ago
I agree with Eric. If they partner with a pharmaceutical company, they might lose control over their vaccine's intellectual property.
upvoted 0 times
...
Eric
11 months ago
I think the biggest risk to Grey Stone is A) Intellectual Property Rights.
upvoted 0 times
...
Arlette
11 months ago
Increased Costs could also be a major concern. The partnership might end up costing more than Grey Stone expected.
upvoted 0 times
...
Willis
11 months ago
I think the biggest risk to Grey Stone is Intellectual Property Rights. They need to make sure their vaccine formula is protected before partnering with the pharma company.
upvoted 0 times
Veronika
10 months ago
C) Low quality product
upvoted 0 times
...
Elke
10 months ago
B) Increased Costs
upvoted 0 times
...
Freeman
10 months ago
A) Intellectual Property Rights
upvoted 0 times
...
...

Save Cancel